机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fengtai District, China,重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[2]China National Clinical Research Center for Neurological Diseases, Beijing, China,[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
Background: The clinical significance of platelet count (PC) for ischemic cerebrovascular disease is not well-established and further risk stratification according to baseline PC within normal range has not been reported before. We aim to evaluate the prognostic effect of baseline circulating PC within normal range on the risk of long-term recurrent stroke, mortality and functional outcomes after ischemic stroke or TIA. Methods: We derived data from eligible patients with ischemic stroke or TIA from the China National Stroke Registry (CNSR) II. Participants were divided into quintiles according to baseline PC within normal range (100-450 x 10(9)/L). Multivariable cox regression and logistic regression were adopted to explore the correlation of baseline PC with recurrent stroke, mortality and poor functional outcomes (modified Rankin Scale 3 similar to 6) within 1-year follow-up. Results: Among the 16842 eligible participants, the average age was 64.7 +/- 11.9, 1,241 (7.4%) had recurrent stroke, 1,377 (8.2%) died, and 3,557 (21.1%) ended up with poor functional outcomes after 1-year follow-up. Compared with the third PC quintile (186-212 x 10(9)/L), patients in the top quintile (249-450 x 10(9)/L) presented with increased risk of recurrent stroke (adjusted hazard ratio 1.21, [1.02-1.45]), all-cause mortality (adjusted hazard ratio 1.43, [1.19-1.73]), and poor functional outcome (adjusted odds ratio 1.49, [1.28-1.74]), while patients in the lowest PC quintile(100-155 x 10(9)/L) had higher risk of poor functional outcome (adjusted odds ratio 1.19, [1.02-1.38]). Conclusion: In ischemic stroke or TIA patients with platelet count within normal range, platelet count may be a qualified predictor for long-term recurrent stroke, mortality, and poor functional outcome.
基金:
National Key R&D Program of China [2017YFC1310900, 2017YFC1310901]; Ministry of Science and Technology of the People's Republic of ChinaMinistry of Science and Technology, China [2012ZX09303, 2011BAI08B02]
第一作者机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fengtai District, China,[2]China National Clinical Research Center for Neurological Diseases, Beijing, China,[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
通讯作者:
通讯机构:[1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fengtai District, China,[2]China National Clinical Research Center for Neurological Diseases, Beijing, China,[3]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,[4]Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
推荐引用方式(GB/T 7714):
Ming Yang,Yuesong Pan,Zixiao Li,et al.Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II[J].FRONTIERS IN NEUROLOGY.2019,10(APR):-.doi:10.3389/fneur.2019.00370.
APA:
Ming Yang,Yuesong Pan,Zixiao Li,Hongyi Yan,Xingquan Zhao...&Yongjun Wang.(2019).Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II.FRONTIERS IN NEUROLOGY,10,(APR)
MLA:
Ming Yang,et al."Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II".FRONTIERS IN NEUROLOGY 10..APR(2019):-